Viewing Study NCT00972933


Ignite Creation Date: 2025-12-25 @ 2:59 AM
Ignite Modification Date: 2025-12-26 @ 1:40 AM
Study NCT ID: NCT00972933
Status: COMPLETED
Last Update Posted: 2017-12-07
First Post: 2009-09-03
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Immunogenicity and Biomarker Analysis of Neoadjuvant Ipilimumab for Melanoma
Sponsor: Diwakar Davar
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module